TENECTEPLASE AS A NEW MEDICATION IN MANAGING NO-REFLOW
No-reflow has been defined as “inadequate myocardial perfusion through a given segment of coronary circulation without angiographic evidence of a mechanical obstruction”. Important components of the process are thought to include endothelial ischemic injury producing “blebs” of tissue that directl...
Main Authors: | Milan Živković, Svetlana Apostolović, Milan Pavlović, Sonja Šalinger Martinović, Tomislav Kostić, Nenad Božinović, Emina Dimitrijević |
---|---|
Format: | Article |
Language: | English |
Published: |
University in Nis, Faculty of Medicine
2012-03-01
|
Series: | Acta Medica Medianae |
Subjects: | |
Online Access: | http://publisher.medfak.ni.ac.rs/2012-html/1-broj/Milan%20Zivkovic-Managing%20no-reflow.pdf |
Similar Items
-
The Predictive Value of CHADS-VASC Score in No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention
by: Ali Farahe, et al.
Published: (2022-11-01) -
CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: L. A. Bondarenko, et al.
Published: (2015-12-01) -
NO-REFLOW PHENOMENON IN THE PRACTICE OF AN ENDOVASCULAR SURGEON
by: A. M. Gerasimov, et al.
Published: (2016-06-01) -
“Goldilocks” Approach to Deferred Stenting in ST‐Segment–Elevation Myocardial Infarction
by: Celina M. Yong, et al.
Published: (2022-05-01) -
Effect of no-reflow/reflow on P-wave time indexes in patients with acute myocardial infarction undergoing percutaneous coronary intervention
by: Ahmet Karakurt, et al.
Published: (2020-01-01)